🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 10 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/06/2001 | 6,96 | 7,03 | 6,94 | 6,98 | -0,29% | 1,22% | 358.400 |
| 05/06/2001 | 6,76 | 7,10 | 6,76 | 7,00 | +3,47% | 4,96% | 396.200 |
| 04/06/2001 | 6,55 | 7,05 | 6,55 | 6,77 | +2,50% | 7,56% | 165.000 |
| 01/06/2001 | 6,60 | 6,75 | 6,38 | 6,60 | +1,54% | 5,61% | 266.800 |
| 31/05/2001 | 6,72 | 6,72 | 6,46 | 6,50 | -0,46% | 3,94% | 240.200 |
| 30/05/2001 | 6,78 | 6,99 | 6,48 | 6,53 | -5,09% | 7,60% | 133.800 |
| 29/05/2001 | 6,91 | 7,03 | 6,88 | 6,88 | +0,00% | 2,10% | 142.200 |
| 25/05/2001 | 6,96 | 7,05 | 6,83 | 6,88 | -1,15% | 3,23% | 237.000 |
| 24/05/2001 | 7,03 | 7,03 | 6,71 | 6,96 | +2,88% | 4,55% | 285.600 |
| 23/05/2001 | 6,82 | 7,00 | 6,75 | 6,77 | -0,07% | 3,67% | 215.600 |
| 22/05/2001 | 7,03 | 7,24 | 6,76 | 6,77 | -3,97% | 6,83% | 487.600 |
| 21/05/2001 | 6,91 | 7,25 | 6,90 | 7,05 | +4,21% | 5,07% | 581.200 |
| 18/05/2001 | 6,89 | 6,94 | 6,75 | 6,77 | -2,66% | 2,69% | 696.600 |
| 17/05/2001 | 6,40 | 7,04 | 6,13 | 6,95 | +12,55% | 14,22% | 509.200 |
| 16/05/2001 | 5,74 | 6,40 | 5,66 | 6,18 | +7,86% | 12,90% | 377.000 |
| 15/05/2001 | 5,63 | 5,78 | 5,58 | 5,73 | +2,14% | 3,55% | 255.000 |
| 14/05/2001 | 5,73 | 5,74 | 5,50 | 5,61 | +1,36% | 4,10% | 242.000 |
| 11/05/2001 | 5,60 | 5,73 | 5,51 | 5,53 | -1,25% | 3,84% | 296.400 |
| 10/05/2001 | 5,50 | 5,62 | 5,50 | 5,60 | +2,19% | 2,09% | 249.000 |
| 09/05/2001 | 5,40 | 5,55 | 5,35 | 5,48 | +1,58% | 3,80% | 176.400 |
| 08/05/2001 | 5,50 | 5,50 | 5,23 | 5,40 | +0,37% | 4,91% | 221.400 |
| 07/05/2001 | 5,48 | 5,60 | 5,36 | 5,38 | -2,71% | 4,47% | 321.400 |
| 04/05/2001 | 5,53 | 5,68 | 5,45 | 5,53 | +0,09% | 4,07% | 188.600 |
| 03/05/2001 | 5,75 | 5,75 | 5,45 | 5,52 | -3,92% | 5,22% | 204.200 |
| 02/05/2001 | 6,03 | 6,03 | 5,25 | 5,75 | -4,17% | 12,86% | 538.000 |
| 01/05/2001 | 6,00 | 6,00 | 5,73 | 6,00 | -0,08% | 4,59% | 254.400 |
| 30/04/2001 | 5,75 | 6,00 | 5,75 | 6,00 | +4,35% | 4,35% | 334.800 |
| 27/04/2001 | 5,60 | 5,82 | 5,59 | 5,75 | +2,86% | 4,02% | 85.200 |
| 26/04/2001 | 5,57 | 5,71 | 5,54 | 5,59 | +0,45% | 3,05% | 168.000 |
| 25/04/2001 | 5,44 | 5,65 | 5,26 | 5,57 | +2,77% | 7,08% | 196.400 |